Posts by: Santiago Gisler

News

The Loop wristband device, designed to remotely monitor the condition of patients with chronic diseases such as chronic obstructive pulmonary disease (COPD), received marketing clearance from the U.S. Food ... Read more

March 22, 2019March 22, 2019

New Tool Identifies Support Needs of COPD Patients, Helping to Make Care More Personal and Holistic

News

A new tool identifying broad areas of need by patients receiving palliative or end-of-life care may improve personalized care for patients with advanced chronic obstructive pulmonary disease (COPD) and ... Read more

March 8, 2019March 8, 2019

DNA Differences May Explain COPD Risk in Both Smokers and Non-smokers, Study Says

News

Differences in DNA may explain lung health and the risk of chronic obstructive pulmonary disease (COPD) in both smokers and non-smokers and could help in the future development of preventive ... Read more

February 22, 2019February 22, 2019

COPD Patients Unaware of Their Higher Risk for Lung Cancer, Study Shows

News

Patients with chronic obstructive pulmonary disease (COPD) are unaware of their increased lung cancer risk compared with the general population — attributing their chest symptoms to factors other than potential cancer ... Read more

February 15, 2019February 15, 2019

Statins Linked to Better Outcomes and Improved Lung Function in COPD Patients, Meta-analysis Finds

News

Statins, commonly used to lower blood cholesterol levels, can help chronic obstructive pulmonary disease (COPD) patients by preventing or treating COPD-related comorbidities, and by improving patients’ lung function and exercise ... Read more

February 5, 2019February 5, 2019

Flu Vaccine Reduces Severe Outcomes in COPD Patients, Canadian Study Shows

News

People with chronic obstructive pulmonary disease (COPD) have an increased risk of severe illness, hospitalization, and death if they become infected with the influenza virus, according to a Canadian ... Read more

January 25, 2019January 25, 2019

Ensifentrine Shows Benefit as Add-on Maintenance Therapy in Phase 2 Trial, Verona Pharma Says

News

Data from a three-day Phase 2 clinical trial offered positive results for nebulized ensifentrine (RPL544) as an add-on treatment for chronic obstructive pulmonary disease (COPD), its developer Verona Pharma announced. Ensifentrine is an inhibitor of ... Read more

January 22, 2019January 22, 2019

Cognitive Behavioral Therapy Reduces COPD-related Anxiety and Hospital Visits, Study Shows

News

Cognitive behavioral therapy (CBT) intervention can alleviate anxiety in people with chronic obstructive pulmonary disease (COPD), and reduce long-term hospital costs, a study shows. The results were published in ... Read more

January 11, 2019January 11, 2019

ProAir Digihaler Approved for COPD and Asthma Patients to Digitally Track Their Albuterol Use

News

The ProAir Digihaler, a digital inhaler that allows patients with asthma and chronic obstructive pulmonary disease (COPD) to track their inhaler usage through a mobile app, has been approved ... Read more

December 4, 2018December 4, 2018

Few COPD Patients Enroll in Pulmonary Rehabilitation, Despite Benefits, Study Shows

News

Very few patients with chronic obstructive pulmonary disease (COPD) start pulmonary rehabilitation after being hospitalized, despite its proven benefits and clinical guidelines recommending it shortly after discharge, a study ... Read more

Posts by: Santiago Gisler

Santiago Gisler

FDA Gives Marketing Clearance to Loop Wearable Wristband that Remotely Monitors COPD Patients

New Tool Identifies Support Needs of COPD Patients, Helping to Make Care More Personal and Holistic

DNA Differences May Explain COPD Risk in Both Smokers and Non-smokers, Study Says

COPD Patients Unaware of Their Higher Risk for Lung Cancer, Study Shows

Statins Linked to Better Outcomes and Improved Lung Function in COPD Patients, Meta-analysis Finds

Flu Vaccine Reduces Severe Outcomes in COPD Patients, Canadian Study Shows

Ensifentrine Shows Benefit as Add-on Maintenance Therapy in Phase 2 Trial, Verona Pharma Says

Cognitive Behavioral Therapy Reduces COPD-related Anxiety and Hospital Visits, Study Shows

ProAir Digihaler Approved for COPD and Asthma Patients to Digitally Track Their Albuterol Use

Few COPD Patients Enroll in Pulmonary Rehabilitation, Despite Benefits, Study Shows

Pin It on Pinterest